All In Biotech

Drug Trial Radar · NCT05796440

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children With Idiopathic Growth Hormone Deficiency

Last checked: Nov 19, 2026Latest source record: Feb 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

60

Planned (sponsor's estimate)

Start

Aug 1, 2023

Primary completion

Mar 2028

Study completion Apr 2028

Sponsor

Lead sponsor
Lumos PharmaIndustry
Sponsor type
Industry
First posted
Apr 3, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 14 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-national trial. The trial aims to study the long-term safety of LUM-201 in subjects with Idiopathic Pediatric Growth Hormone Deficiency (iPGHD). This study will also assess pharmacodynamics and efficacy response to therapy with LUM-201.

Conditions

  • Growth Hormone Deficiency

Interventions

  • LUM-201Drug

    Administered orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of treatment-emergent adverse eventsTime frame: Day 1 to Month 36

Locations

7 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Iowa

    Iowa City, Iowa

  • UMass Memorial Medical Center

    Worcester, Massachusetts

  • Children's Mercy Hospital

    Kansas City, Missouri

  • University of South Carolina

    Charleston, South Carolina

  • Texas Tech University Health Sciences Center

    Amarillo, Texas

  • Seattle Children's Hospital

    Seattle, Washington

  • Canberra Hospital

    Garran, Australian Capital Territory, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.